Author: Dagny Stuart
Jun. 22, 2017—Lauren Hackett, MPA, executive director of Administration and chief business officer for Vanderbilt-Ingram Cancer Center (VICC), has been elected to serve on the Finance Committee for the National Comprehensive Cancer Network (NCCN).
Jun. 16, 2017—Patients with aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other blood disorders are invited to a free seminar featuring a Vanderbilt University Medical Center clinician and other medical experts.
Jun. 15, 2017—Staff members from Vanderbilt-Ingram Cancer Center (VICC) garnered an impressive second place finish in last month’s Downtown Derby Bed Race competition. The annual event which raises funds for the T.J. Martell Foundation featured teams that built and decorated their own “beds” to race up 5th Avenue to Bridgestone Plaza in downtown Nashville. The VICC team,...
Jun. 13, 2017—Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center.
Jun. 8, 2017—Clinical geneticist Tuya Pal, M.D., has joined Vanderbilt-Ingram Cancer Center (VICC) as associate director of Cancer Health Disparities. Pal also has been named an associate professor of Medicine and Ingram Associate Professor of Cancer Research.
Jun. 8, 2017—An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.
May. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, will host a free seminar, “Are You at High Risk for Breast Cancer?”
May. 25, 2017—The CEO Roundtable on Cancer has re-accredited Vanderbilt University Medical Center (VUMC) as a CEO Cancer Gold Standard employer for 2017 for VUMC’s efforts to reduce the risk of cancer for employees and their families.
May. 11, 2017—Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer.
May. 4, 2017—Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI).
Apr. 24, 2017— Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected to The American Society for Clinical Investigation (ASCI). The ASCI is an elite honor society of physician-scientists. The Society, founded in 1908, is home to nearly 3,000 members from the upper ranks of academic...